• 2021
  Gosset A, Diallo MY, Betsem E, Schaeffer L, Meda N, Vray M, Sombie R, Shimakawa Y, Boyer S, , Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study)., Vaccine 2021 Jul; (): .
• 2021
  Ndow G, Cessay A, Cohen D, Shimakawa Y, Gore ML, Tamba S, Ghosh S, Sanneh B, Baldeh I, Njie R, D'Alessandro U, Mendy M, Thursz M, Chemin I, Lemoine M, , Prevalence and clinical significance of occult hepatitis B infection in The Gambia, West Africa., J Infect Dis 2021 Jun; (): .
• 2021
  Moutchia J, Njouom R, Rumpler E, Besombes C, Texier G, Tejiokem M, Crépey P, Fontanet A, Shimakawa Y, , Maternal age at first childbirth and geographical variation in HBV prevalence in Cameroon: Important role of mother-to-child transmission., Clin Infect Dis 2021 Jun; (): .
• 2021
  Tall H, Adam P, Tiendrebeogo ASE, Vincent JP, Schaeffer L, von Platen C, Fernandes-Pellerin S, Sawadogo F, Bokoum A, Bouda G, Ouattara S, Ouédraogo I, Herrant M, Boucheron P, Sawadogo A, Betsem E, Essoh A, Kabore L, Ouattara A, Méda N, Hien H, Gosset A, Giles-Vernick T, Boyer S, Kania D, Vray M, Shimakawa Y, , Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study)., Vaccines (Basel) 2021 Jun; 9(6): .
• 2021
  Gosset A, Nishimwe ML, Diallo MY, Deroo L, Diallo A, Ba EH, Carrieri PM, Sokhna C, Vray M, Shimakawa Y, Boyer S, , The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study)., Vaccines (Basel) 2021 May; 9(5): .
• 2021
  Vanhomwegen J, Kwasiborski A, Diop A, Boizeau L, Hoinard D, Vray M, Bercion R, Ndiaye B, Dublineau A, Michiyuki S, Manuguerra JC, Sauvage V, Candotti D, Seck A, Laperche S, Shimakawa Y, , Development and clinical validation of loop-mediated isothermal amplification (LAMP) assay to diagnose high HBV DNA levels in resource-limited settings., Clin Microbiol Infect 2021 Apr; (): .
• 2021
  Kim JU, Ingiliz P, Shimakawa Y, Lemoine M, , Improving care of migrants is key for viral hepatitis elimination in Europe., Bull World Health Organ 2021 Apr; 99(4): 280-286.
• 2021
  Post G, Howell J, Sow A, Ndow G, Chemin I, Lo G, Cessay A, Cohen D, Njie R, Toure S, Diop M, Sombie R, Nana J, Leroy V, Lacombe K, Bojang L, Tacke F, Toure-Kane C, Ka M, Mendy M, Mboup S, Thursz M, Shimakawa Y, Ingiliz P, Lemoine M, , Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B., J Viral Hepat 2021 Mar; (): .
• 2021
  Vo Quang E, Shimakawa Y, Nahon P, , Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination., Liver Int 2021 Feb; (): .
• 2021
  Shimakawa Y, Vernoux L, Gabassi A, Mercier-Delarue S, Vincent JP, Simon F, Maylin S, , Analytical validation of hepatitis B core-related antigen (HBcrAg) using dried blood spots (DBS)., J Viral Hepat 2021 Feb; (): .
• 2020
  Hai VV, Shimakawa Y, Kim J, Do Ngoc H, Le Minh Q, Laureillard D, Lemoine M, , Assessment and simplification of treatment eligibility among patients with chronic hepatitis B infection in Vietnam., Clin Infect Dis 2020 Dec; (): .
• 2020
  Cohen D, Ghosh S, Shimakawa Y, Ramou N, Garcia PS, Dubois A, Guillot C, Kakwata-Nkor Deluce N, Tilloy V, Durand G, Voegele C, Ndow G, d'Alessandro U, Brochier-Armanet C, Alain S, Le Calvez-Kelm F, Hall J, Zoulim F, Mendy M, Thursz M, Lemoine M, Chemin I, , Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma., JHEP Rep 2020 Oct; 2(5): 100144.
• 2020
  Lemoine M, Kim JU, Ndow G, Bah S, Forrest K, Rwegasha J, Bouyou M, Napon D, Somda S, Sawadogo A, Sombie R, Shimakawa Y, , Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa., Lancet Gastroenterol Hepatol 2020 Sep; (): .
• 2020
  Shimakawa Y, Lemoine M, , Reply to: “Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age”., J. Hepatol. 2020 Aug; (): .
• 2020
  Funk AL, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, Chou R, Bulterys M, Shimakawa Y, , Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis., Lancet Infect Dis 2020 Aug; (): .
• 2020
  Boucheron P, Lu Y, Yoshida K, Zhao T, Funk AL, Lunel-Fabiani F, Guingané A, Tuaillon E, van Holten J, Chou R, Bulterys M, Shimakawa Y, , Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis., Lancet Infect Dis 2020 Aug; (): .
• 2020
  Bassoum O, Kimura M, Tal Dia A, Lemoine M, Shimakawa Y, , Coverage and Timeliness of Birth Dose Vaccination in Sub-Saharan Africa: A Systematic Review and Meta-Analysis., Vaccines (Basel) 2020 Jun; 8(2): .
• 2020
  Yoshida K, Desbiolles A, Feldman SF, Ahn SH, Alidjinou EK, Atsukawa M, Bocket L, Brunetto MR, Buti M, Carey I, Caviglia GP, Chen EQ, Cornberg M, Enomoto M, Honda M, Zu Siederdissen CH, Ishigami M, Janssen H, Maasoumy B, Matsui T, Matsumoto A, Nishiguchi S, Riveiro-Barciela M, Takaki A, Tangkijvanich P, Toyoda H, van Campenhout MJ, Wang B, Wei L, Yang HI, Yano Y, Yatsuhashi H, Yuen MF, Tanaka E, Lemoine M, Tanaka Y, Shimakawa Y, Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data, Clin. Gastroenterol. Hepatol. 2020 Apr;.
• 2020
  Shah R, Boucheron P, Mandaliya K, Kattamaiyo A, Chevaliez S, Shimakawa Y, Songok E, Lemoine M, Hepatitis C virus infection in people who inject drugs in Africa, Lancet Infect Dis 2020 Mar;20(3):282-283.
• 2020
  Boye S, Shimakawa Y, Vray M, Giles-Vernick T, , Limited Awareness of Hepatitis B but Widespread Recognition of Its Sequelae in Rural Senegal: A Qualitative Study., Am J Trop Med Hyg 2020 03; 102(3): 637-643.
• 2020
  Mohamed Z, Al-Kurdi D, Nelson M, Shimakawa Y, Selvapatt N, Lacey J, Thursz MR, Lemoine M, Brown AS, , Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England., Int J Drug Policy 2020 01; 75(): 102608.
• 2019
  Mohamed Z, Mbwambo J, Rwegasha J, Mgina N, Doulla B, Mwakale P, Tuaillon E, Chevaliez S, Shimakawa Y, Taylor-Robinson SD, Thursz MR, Brown AS, Lemoine M, In-field evaluation of Xpert® HCV viral load fingerstick assay in people who inject drugs in Tanzania, Liver Int. 2019 Nov;.
• 2019
  Nayagam S, Shimakawa Y, Lemoine M, Mother to child transmission of hepatitis B: What more needs to be done to eliminate it around the world?, J. Viral Hepat. 2019 Nov;.
• 2019
  Shimakawa Y, Boucheron P, Luong Nguyen LB, Lemoine M, Sombié R, , Performance of two simplified HBV treatment criteria (TREAT-B score and WHO guidelines) in Burkina Faso, West Africa., J Hepatol 2019 10; 71(4): 842-844.
• 2019
  Shimakawa Y, Ndow G, Njie R, Njai HF, Takahashi K, Akbar SMF, Cohen D, Nayagam S, Jeng A, Ceesay A, Sanneh B, Baldeh I, Imaizumi M, Moriyama K, Aoyagi K, D'Alessandro U, Mishiro S, Chemin I, Mendy M, Thursz MR, Lemoine M, Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa, Clin. Infect. Dis. 2019 May;.
• 2019
  Cohen D, Shimakawa Y, Ndow G, Sow A, Tamba S, Njie R, Lo G, Ghosh S, Toure-Kane C, Ka M, Mboup S, Okeke E, Toure S, Diop M, D'Alessandro U, Taylor-Robinson S, Mendy M, Zoulim F, Thursz MR, Lemoine M, Chemin I, , [Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study]., Med Sci (Paris) 2019 May; 35(5): 431-439.
• 2019
  Yoshida K, Post G, Shimakawa Y, Thursz M, Brown A, Ingiliz P, Lemoine M, Clinical utility of TREAT-B score in African and non-African HBV-infected patients living in Europe, J. Hepatol. 2019 Apr;.
• 2019
  Post G, Shalev N, Baumgarten A, Shimakawa Y, Lemoine M, Krznaric I, Dupke S, Carganico A, Arastéh K, Ingiliz P, Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection, Eur J Gastroenterol Hepatol 2019 Apr;.
• 2019
  Mohamed Z, Kim JU, Magesa A, Kasubi M, Feldman SF, Chevaliez S, Mwakale P, Taylor-Robinson SD, Thursz MR, Shimakawa Y, Rwegasha J, Lemoine M, High prevalence and poor linkage to care of transfusion-transmitted infections among blood donors in Dar-es-Salaam, Tanzania, J. Viral Hepat. 2019 Feb;.
• 2019
  Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou J, Howell J, Jia J, Kravchenko N, Lazarus JV, Lemoine M, Lesi OA, Maistat L, McMahon BJ, Razavi H, Roberts T, Simmons B, Sonderup MW, Spearman CW, Taylor BE, Thomas DL, Waked I, Ward JW, Wiktor SZ, , Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission, Lancet Gastroenterol Hepatol 2019 Feb;4(2):135-184.
• 2018
  Mohamed Z, Rwegasha J, Kim JU, Shimakawa Y, Poiteau L, Chevaliez S, Bhagani S, Taylor-Robinson SD, Thursz MR, Mbwambo J, Lemoine M, The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania, J. Viral Hepat. 2018 Jul;.
• 2018
  Shimakawa Y, Njie R, Ndow G, Vray M, Mbaye PS, Bonnard P, Sombié R, Nana J, Leroy V, Bottero J, Ingiliz P, Post G, Sanneh B, Baldeh I, Suso P, Ceesay A, Jeng A, Njai HF, Nayagam S, D'Alessandro U, Chemin I, Mendy M, Thursz M, Lemoine M, Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa, J. Hepatol. 2018 Jun;.
• 2018
  El Kassas M, Funk AL, Abd El Latif Y, Vasiliu A, Sherief A, Shimakawa Y, Youssef N, El Tahan A, Elbadry M, Farid AM, El Shazly Y, Doss W, Esmat G, Fontanet A, Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt, Aliment. Pharmacol. Ther. 2018 Jun;47(11):1564-1566.
• 2018
  Seck A, Ndiaye F, Maylin S, Ndiaye B, Simon F, Funk AL, Fontanet A, Takahashi K, Akbar SMF, Mishiro S, Bercion R, Vray M, Shimakawa Y, Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa, Am. J. Trop. Med. Hyg. 2018 Aug;99(2):428-434.
• 2018
  El Kassas M, Shimakawa Y, Ali-Eldin Z, Funk AL, Wifi MN, Zaky S, El-Raey F, Esmat G, Fontanet A, Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data, Liver Int. 2018 May;.
• 2018
  Llibre A, Shimakawa Y, Mottez E, Ainsworth S, Buivan TP, Firth R, Harrison E, Rosenberg AR, Meritet JF, Fontanet A, Castan P, Madejón A, Laverick M, Glass A, Viana R, Pol S, McClure CP, Irving WL, Miele G, Albert ML, Duffy D, Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus, Gut 2018 Nov;67(11):2017-2024.
• 2018
  Shimakawa Y, Seck A, Nayagam S, Toure-Kane C, Lemoine M, Screening strategies to prevent mother-to-child transmission of hepatitis B in sub-Saharan Africa, Lancet Gastroenterol Hepatol 2018 Apr;3(4):222-223.
• 2018
  Lemoine M, Mohamed Z, Chevaliez S, Shimakawa Y, Rwegasha J, Role of hepatitis C virus core antigen assay in hepatitis C care in Africa, Lancet Gastroenterol Hepatol 2018 Apr;3(4):223-224.
• 2018
  El Kassas M, Funk AL, Salaheldin M, Shimakawa Y, Eltabbakh M, Jean K, El Tahan A, Sweedy AT, Afify S, Youssef NF, Esmat G, Fontanet A, Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis, J. Viral Hepat. 2018 06;25(6):623-630.
• 2017
  Mohamed Z, Mbwambo J, Shimakawa Y, Poiteau L, Chevaliez S, Pawlotsky JM, Rwegasha J, Bhagani S, Simon D TR, Makani J, Thursz MR, Lemoine M, Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania, J Int AIDS Soc 2017 Sep;20(1):1-7.
• 2017
  Andriamandimby SF, Olive MM, Shimakawa Y, Rakotomanana F, Razanajatovo IM, Andrianinarivomanana TM, Ravalohery JP, Andriamamonjy S, Rogier C, Héraud JM, Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO’s elimination strategy, BMC Public Health 2017 Aug;17(1):636.
• 2017
  Shimakawa Y, Pourette D, Bainilago L, Enel C, Sombié R, Rado R, Lemoine M, Giles-Vernick T, Improving communication about viral hepatitis in Africa, Lancet Infect Dis 2017 07;17(7):688-689.
• 2017
  Ndow G, Gore ML, Shimakawa Y, Suso P, Jatta A, Tamba S, Sow A, Touré-Kane C, Sadiq F, Sabally S, Njie R, Thursz MR, Lemoine M, Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes, PLoS ONE 2017;12(6):e0179025.
• 2017
  Shimakawa Y, Lemoine M, Early age at diagnosis of hepatocellular carcinoma in sub-Saharan Africa, Lancet Gastroenterol Hepatol 2017 Jun;2(6):393.
• 2017
  Nayagam S, Conteh L, Sicuri E, Shimakawa Y, Lemoine M, Hallett TB, Thursz M, Community-based screening and treatment for chronic hepatitis B in sub-Saharan Africa – Authors’ reply, Lancet Glob Health 2017 Jan;5(1):e35.
• 2016
  Giles-Vernick T, Hejoaka F, Sanou A, Shimakawa Y, Bamba I, Traoré A, Barriers to Linkage to Care for Hepatitis B Virus Infection: A Qualitative Analysis in Burkina Faso, West Africa, Am. J. Trop. Med. Hyg. 2016 Dec;95(6):1368-1375.
• 2016
  Keane E, Funk AL, Shimakawa Y, Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa, Aliment. Pharmacol. Ther. 2016 Sep;.
• 2016
  Lemoine M, Shimakawa Y, Njie R, Taal M, Ndow G, Chemin I, Ghosh S, Njai HF, Jeng A, Sow A, Toure-Kane C, Mboup S, Suso P, Tamba S, Jatta A, Sarr L, Kambi A, Stanger W, Nayagam S, Howell J, Mpabanzi L, Nyan O, Corrah T, Whittle H, Taylor-Robinson SD, D'Alessandro U, Mendy M, Thursz MR, , Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study, Lancet Glob Health 2016 Aug;4(8):e559-67.
• 2016
  Nayagam S, Conteh L, Sicuri E, Shimakawa Y, Suso P, Tamba S, Njie R, Njai H, Lemoine M, Hallett TB, Thursz M, Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis, Lancet Glob Health 2016 Aug;4(8):e568-78.
• 2016
  Shimakawa Y, Bonnard P, El Kassas M, Abdel-Hamid M, Esmat G, Fontanet A, Diagnostic accuracy of the γ-glutamyl transpeptidase to platelet ratio to predict liver fibrosis in Egyptian patients with HCV genotype 4, Gut 2016 Jul;.
• 2016
  Miyahara R, Jasseh M, Gomez P, Shimakawa Y, Greenwood B, Keita K, Ceesay S, D'Alessandro U, Roca A, Barriers to timely administration of birth dose vaccines in The Gambia, West Africa, Vaccine 2016 May;.
• 2016
  Lemoine M, Thursz M, Mallet V, Shimakawa Y, Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio (GPR) using transient elastography as a reference, Gut 2016 Feb;.
• 2016
  Mostafa A, Shimakawa Y, Medhat A, Mikhail NN, Chesnais CB, Arafa N, Bakr I, El Hoseiny M, El-Daly M, Esmat G, Abdel-Hamid M, Mohamed MK, Fontanet A, Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural Egypt, J. Hepatol. 2016 Jun;64(6):1240-6.
• 2016
  Shimakawa T, Shimakawa Y, Kawasoe Y, Yoshimura K, Chinen Y, Eimon K, Chibana W, Shirota S, Kadekawa K, Bahr R, Uezato T, Ikeda H, Beach Soccer Injuries During the Japanese National Championships, Orthop J Sports Med 2016 Jan;4(1):2325967115625636.
• 2016
  Shimakawa Y, Toure-Kane C, Mendy M, Thursz M, Lemoine M, Mother-to-child transmission of hepatitis B in sub-Saharan Africa, Lancet Infect Dis 2016 Jan;16(1):19-20.
• 2015
  Shimakawa Y, Njai HF, Takahashi K, Berg L, Ndow G, Jeng-Barry A, Ceesay A, Tamba S, Opoku E, Taal M, Akbar SM, Arai M, D'Alessandro U, Taylor-Robinson SD, Njie R, Mishiro S, Thursz MR, Lemoine M, Hepatitis E virus infection and acute-on-chronic liver failure in West Africa: a case-control study from The Gambia, Aliment. Pharmacol. Ther. 2015 Dec;.
• 2015
  Shimakawa Y, Lemoine M, Njai HF, Bottomley C, Ndow G, Goldin RD, Jatta A, Jeng-Barry A, Wegmuller R, Moore SE, Baldeh I, Taal M, D'Alessandro U, Whittle H, Njie R, Thursz M, Mendy M, Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia, Gut 2015 Jul;.
• 2015
  Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J, Goldin R, Njai HF, Ndow G, Taal M, Cooke G, D'Alessandro U, Vray M, Mbaye PS, Njie R, Mallet V, Thursz M, The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa, Gut 2015 Jun;.
• 2015
  Shimakawa Y, Lemoine M, Bottomley C, Njai HF, Ndow G, Jatta A, Tamba S, Bojang L, Taal M, Nyan O, D'Alessandro U, Njie R, Thursz M, Hall AJ, Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia, Liver Int. 2015 Feb;.
• 2015
  Njai HF, Shimakawa Y, Sanneh B, Ferguson L, Ndow G, Mendy M, Sow A, Lo G, Toure-Kane C, Tanaka J, Taal M, D'alessandro U, Njie R, Thursz M, Lemoine M, Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa, J. Clin. Microbiol. 2015 Apr;53(4):1156-63.
• 2014
  Shimakawa Y, Takao Y, Anderson ST, Taal M, Yamaguchi T, Giana L, Ndow G, Sarr L, Kambi A, Njai HF, Bottomley C, Nyan O, Sabally S, D'Alessandro U, Taylor-Robinson SD, Thursz M, Lemoine M, Njie R, The prevalence and burden of symptoms in patients with chronic liver diseases in The Gambia, West Africa, Palliat Med 2015 Feb;29(2):184-5.
• 2014
  Ladep NG, Dona AC, Lewis MR, Crossey MM, Lemoine M, Okeke E, Shimakawa Y, Duguru M, Njai HF, Fye HK, Taal M, Chetwood J, Kasstan B, Khan SA, Garside DA, Wijeyesekera A, Thillainayagam AV, Banwat E, Thursz MR, Nicholson JK, Njie R, Holmes E, Taylor-Robinson SD, Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans, Hepatology 2014 Oct;60(4):1291-301.
• 2014
  Shimakawa Y, Lemoine M, Mendy M, Njai HF, D'Alessandro U, Hall A, Thursz M, Njie R, Population-based interventions to reduce the public health burden related with hepatitis B virus infection in the gambia, west Africa, Trop Med Health 2014 Jun;42(2 Suppl):59-64.
• 2014
  Shimakawa Y, Bottomley C, Njie R, Mendy M, The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children, BMC Public Health 2014;14:532.
• 2014
  Lemoine M, Shimakawa Y, Nayagam S, Njie R, Thursz M, Commentary: how long does one need to fast before a Fibroscan examination? Authors’ reply, Aliment. Pharmacol. Ther. 2014 Mar;39(5):541-2.
• 2013
  Lemoine M, Shimakawa Y, Njie R, Njai HF, Nayagam S, Khalil M, Goldin R, Ingiliz P, Taal M, Nyan O, Corrah T, D'Alessandro U, Thursz M, Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia, Aliment. Pharmacol. Ther. 2014 Jan;39(2):188-96.
• 2013
  Shimakawa Y, Yan HJ, Tsuchiya N, Bottomley C, Hall AJ, Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review, PLoS ONE 2013;8(7):e69430.
• 2012
  Shimakawa Y, Bah E, Wild CP, Hall AJ, Evaluation of data quality at the Gambia national cancer registry, Int. J. Cancer 2013 Feb;132(3):658-65.
• 2010
  Shimakawa Y, Camélique O, Ariyoshi K, Outbreak of chickenpox in a refugee camp of northern Thailand, Confl Health 2010;4:4.